Research Square (Research Square),
Journal Year:
2022,
Volume and Issue:
unknown
Published: Sept. 20, 2022
Abstract
Objective
Despite
the
improved
lesion
detectability
as
outcome
of
18
F-FDG
PET/MR,
small
distant
metastasis
pancreatic
ductal
adenocarcinoma
(PDAC)
often
remains
invisible.
Our
goal
is
to
explore
potential
joint
radiomics
analysis
PET
and
MRI
imaging
(PET-MRI)
primary
tumors
for
predicting
risk
in
patients
with
PDAC.
Methods
Nighty
one
PDAC
before
confirmation
or
exclusion
SDM
were
retrospectively
investigated.
Among
them,
66
who
received
PET/CT
multi-sequence
separately
included
development
model
(development
cohort),
25
scanned
hybrid
PET/MR
incorporated
independent
verification
(external
test
cohort).
A
signature
was
constructed
using
selected
PET-MRI
features
tumors.
Furthermore,
a
nomogram
developed
by
combining
clinical
indicators
assisting
this
way
assessment
patients’
risk.
Results
In
cohort,
had
better
performance
[area
under
curve
(AUC):
0.93,
sensitivity:87.0%,
specificity:85.0%]
than
(AUC:
0.70,
P
<
0.001;
sensitivity:
70%,
specificity:
65%),
well
0.89,
>
0.05;
65%,
100%).
For
external
test,
yielded
an
AUC
0.85,
sensitivity
78.6%,
specificity
90.9%,
which
comparable
(P
=
0.34).
Conclusions
The
preliminary
results
confirmed
MRI-based
robust
effective
prediction
preoperative
patients.
in-depth
tumor
may
offer
complementary
information
provide
hints
cancer
staging.
Journal of Magnetic Resonance Imaging,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 9, 2025
Pancreatic
ductal
adenocarcinoma
(PDAC)
is
the
deadliest
malignant
tumor,
with
a
grim
5‐year
overall
survival
rate
of
about
12%.
As
its
incidence
and
mortality
rates
rise,
it
likely
to
become
second‐leading
cause
cancer‐related
death.
The
radiological
assessment
determined
stage
management
PDAC.
However,
highly
heterogeneous
disease
complexity
tumor
microenvironment,
challenging
adequately
reflect
biological
aggressiveness
prognosis
accurately
through
morphological
evaluation
alone.
With
dramatic
development
artificial
intelligence
(AI),
multiparametric
magnetic
resonance
imaging
(mpMRI)
using
specific
contrast
media
special
techniques
can
provide
functional
information
high
image
quality
powerful
tool
in
quantifying
intratumor
characteristics.
Besides,
AI
has
been
widespread
field
medical
analysis.
Radiomics
high‐throughput
mining
quantitative
features
from
that
enables
data
be
extracted
applied
for
better
decision
support.
Deep
learning
subset
neural
network
algorithms
automatically
learn
feature
representations
data.
AI‐enabled
biomarkers
mpMRI
have
enormous
promise
bridge
gap
between
personalized
medicine
demonstrate
huge
advantages
predicting
characteristics
current
AI‐based
models
PDAC
operate
mainly
realm
single
modality
relatively
small
sample
size,
technical
reproducibility
interpretation
present
barrage
new
potential
challenges.
In
future,
integration
multi‐omics
data,
such
as
radiomics
genomics,
alongside
establishment
standardized
analytical
frameworks
will
opportunities
increase
robustness
interpretability
bring
these
closer
clinical
practice.
Evidence
Level
3
Technical
Efficacy
Stage
4
Frontiers in Oncology,
Journal Year:
2022,
Volume and Issue:
12
Published: July 6, 2022
This
study
aims
to
uncover
and
validate
an
MRI-based
radiomics
nomogram
for
detecting
lymph
node
metastasis
(LNM)
in
pancreatic
ductal
adenocarcinoma
(PDAC)
patients
prior
surgery.We
retrospectively
collected
141
with
pathologically
confirmed
PDAC
who
underwent
preoperative
T2-weighted
imaging
(T2WI)
portal
venous
phase
(PVP)
contrast-enhanced
T1-weighted
(T1WI)
scans
between
January
2017
December
2021.
The
were
randomly
divided
into
training
(n
=
98)
validation
43)
cohorts
at
a
ratio
of
7:3.
For
each
sequence,
1037
features
extracted
analyzed.
After
applying
the
gradient-boosting
decision
tree
(GBDT),
key
MRI
selected.
Three
scores
(rad-score
1
PVP,
rad-score
2
T2WI,
3
T2WI
combined
PVP)
calculated.
Rad-score
clinical
independent
risk
factors
construct
prediction
LNM
by
multivariable
logistic
regression
analysis.
predictive
performances
rad-scores
assessed
area
under
operating
characteristic
curve
(AUC),
utility
was
analysis
(DCA).Six
eight
PVP
ten
found
be
associated
LNM.
Multivariate
showed
that
MRI-reported
LN
status
predictors.
In
cohorts,
AUCs
1,
0.769
0.751,
0.807
0.784,
0.834
0.807,
respectively.
value
similar
both
(P
>
0.05).
constructed
encouraging
benefit,
AUC
0.845
cohort
0.816
cohort.The
derived
from
based
on
outstanding
performance
PDAC.
Cancers,
Journal Year:
2023,
Volume and Issue:
15(5), P. 1613 - 1613
Published: March 5, 2023
This
study
aimed
to
establish
a
new
clinical-radiomics
nomogram
based
on
ultrasound
(US)
for
cervical
lymph
node
metastasis
(LNM)
in
papillary
thyroid
carcinoma
(PTC).
We
collected
211
patients
with
PTC
between
June
2018
and
April
2020,
then
we
randomly
divided
these
into
the
training
set
(n
=
148)
validation
63).
837
radiomics
features
were
extracted
from
B-mode
(BMUS)
images
contrast-enhanced
(CEUS)
images.
The
maximum
relevance
minimum
redundancy
(mRMR)
algorithm,
least
absolute
shrinkage
selection
operator
(LASSO)
backward
stepwise
logistic
regression
(LR)
applied
select
key
score
(Radscore),
including
BMUS
Radscore
CEUS
Radscore.
clinical
model
established
using
univariate
analysis
multivariate
LR.
was
finally
presented
as
nomogram,
performance
of
which
evaluated
by
receiver
operating
characteristic
curves,
Hosmer-Lemeshow
test,
calibration
decision
curve
(DCA).
results
show
that
constructed
four
predictors,
gender,
age,
US-reported
LNM,
performed
well
both
(AUC
0.820)
0.814).
test
curves
demonstrated
good
calibration.
DCA
showed
had
satisfactory
utility.
can
be
used
an
effective
tool
individualized
prediction
LNM
PTC.
Insights into Imaging,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 30, 2025
Abstract
Objectives
To
develop
and
validate
a
contrast-enhanced
MRI-based
intratumoral
heterogeneity
(ITH)
model
for
predicting
lymph
node
(LN)
metastasis
in
resectable
pancreatic
ductal
adenocarcinoma
(PDAC).
Methods
Lesions
were
encoded
into
different
habitats
based
on
enhancement
ratios
at
arterial,
venous,
delayed
phases
of
MRI.
Habitat
models
enhanced
ratio
mapping
single
sequences,
radiomic
models,
clinical
developed
evaluating
LN
metastasis.
The
performance
the
was
evaluated
via
metrics.
Additionally,
patients
stratified
high-risk
low-risk
groups
an
ensembled
to
assess
prognosis
after
adjuvant
therapy.
Results
We
radiomics–habitat–clinical
(RHC)
that
integrates
radiomics,
habitat,
data
precise
prediction
PDAC.
RHC
showed
strong
predictive
performance,
with
area
under
curve
(AUC)
values
0.805,
0.779,
0.615
derivation,
internal
validation,
external
validation
cohorts,
respectively.
Using
optimal
threshold
0.46,
effectively
patients,
revealing
significant
differences
recurrence-free
survival
overall
(OS)
(
p
=
0.004
<
0.001).
Adjuvant
therapy
improved
OS
group
0.004),
but
no
benefit
observed
0.069).
Conclusion
ITH
provides
reliable
estimates
PDAC
may
offer
additional
value
guiding
decision-making.
Critical
relevance
statement
This
ensemble
facilitates
preoperative
using
offers
foundation
prognostic
assessment
supports
management
personalized
treatment
strategies.
Key
Points
habitat
can
predict
Both
radiomics
characteristics
useful
have
potential
enhance
accuracy
inform
therapeutic
decisions.
Graphical
Cancers,
Journal Year:
2022,
Volume and Issue:
14(14), P. 3498 - 3498
Published: July 19, 2022
Pancreatic
ductal
adenocarcinoma
(PDAC),
estimated
to
become
the
second
leading
cause
of
cancer
deaths
in
western
societies
by
2030,
was
flagged
as
a
neglected
European
Commission
and
United
States
Congress.
Due
lack
investment
research
development,
combined
with
complex
aggressive
tumour
biology,
PDAC
overall
survival
has
not
significantly
improved
past
decades.
Cross-sectional
imaging
histopathology
play
crucial
role
throughout
patient
pathway.
However,
current
clinical
guidelines
for
diagnostic
workup,
stratification,
treatment
response
assessment,
follow-up
are
non-uniform
evidence-based
consensus.
Artificial
Intelligence
(AI)
can
leverage
multimodal
data
improve
outcomes,
but
AI
is
too
scattered
lacking
quality
be
incorporated
into
workflows.
This
review
describes
pathway
derives
touchpoints
image-based
collaboration
multi-disciplinary,
multi-institutional
expert
panel.
The
literature
exploring
address
these
thoroughly
retrieved
analysed
identify
existing
trends
knowledge
gaps.
results
show
absence
multi-institutional,
well-curated
datasets,
an
essential
building
block
robust
applications.
Furthermore,
most
unimodal,
does
use
state-of-the-art
techniques,
lacks
reliable
ground
truth.
Based
on
this,
future
agenda
clinically
relevant,
image-driven
proposed.
Acta Radiologica,
Journal Year:
2022,
Volume and Issue:
64(7), P. 2221 - 2228
Published: Dec. 6, 2022
The
preoperative
prediction
of
lymph
node
metastasis
(LNM)
in
pancreatic
ductal
adenocarcinoma
(PDAC)
is
essential
prognosis
and
treatment
strategy
formulation.To
compare
the
performance
computed
tomography
(CT)
magnetic
resonance
imaging
(MRI)
radiomics
models
for
LNM
PDAC.In
total,
160
consecutive
patients
with
PDAC
were
retrospectively
included,
who
divided
into
training
validation
sets
(ratio
8:2).
Two
radiologists
evaluated
basing
on
morphological
abnormalities.
Radiomics
features
extracted
from
T2-weighted
imaging,
T1-weighted
multiphase
contrast
enhanced
MRI
CT,
respectively.
Overall,
1184
each
volume
interest
drawn.
Only
an
intraclass
correlation
coefficient
≥0.75
included.
Three
sequential
feature
selection
steps-variance
threshold,
variance
thresholding
least
absolute
shrinkage
operator-were
repeated
20
times
fivefold
cross-validation
set.
based
CT
multiparametric
built
five
most
frequent
features.
Model
was
using
area
under
curve
(AUC)
values.Multiparametric
model
achieved
improved
AUCs
(0.791
0.786
sets,
respectively)
than
that
(0.672
0.655
radiologists'
assessment
(0.600-0.613
0.560-0.587
respectively).Multiparametric
may
serve
as
a
potential
tool
preoperatively
evaluating
had
superior
predictive
to
CT-based
assessment.